Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume 226, Issue -, Pages 109422
Publisher
Elsevier BV
Online
2023-01-14
DOI
10.1016/j.neuropharm.2023.109422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmahuasca and DMT Rescue ROS Production and Differentially Expressed Genes Observed after Predator and Psychosocial Stress: Relevance to Human PTSD
- (2022) D. Parker Kelley et al. ACS Chemical Neuroscience
- Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review
- (2022) Danika Dai et al. BMC Psychiatry
- Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats
- (2022) Helena M. Abelaira et al. MOLECULAR NEUROBIOLOGY
- Ketamine enhances dopamine D1 receptor expression by modulating microRNAs in a ketamine-induced schizophrenia-like mouse model
- (2022) Xiao-jin Li et al. NEUROTOXICOLOGY AND TERATOLOGY
- Classic Psychedelic Drugs: Update on Biological Mechanisms
- (2022) Franz X. Vollenweider et al. PHARMACOPSYCHIATRY
- Structure-based discovery of nonhallucinogenic psychedelic analogs
- (2022) Dongmei Cao et al. SCIENCE
- Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study
- (2022) Grant M. Jones et al. Scientific Reports
- Combined Administration of (R)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism
- (2022) Anna Rafało-Ulińska et al. Pharmaceuticals
- P310. Effect of a Sub-Anesthetic Infusion of Ketamine on Laboratory-Induced Stress in Healthy Volunteers: A Proof-Of-Concept Translational Study
- (2022) Sara Costi et al. BIOLOGICAL PSYCHIATRY
- Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience
- (2022) Francisco Madrid-Gambin et al. BIOMEDICINE & PHARMACOTHERAPY
- Exaggerated Amygdala Response to Threat and Association with Immune Hyperactivity in Depression
- (2022) Sarah Boukezzi et al. BRAIN BEHAVIOR AND IMMUNITY
- mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression
- (2022) Lynnette A. Averill et al. JOURNAL OF AFFECTIVE DISORDERS
- The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: A systematic review and updated meta-analysis of double-blind randomized controlled trials
- (2022) Tien-Wei Hsu et al. JOURNAL OF AFFECTIVE DISORDERS
- Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
- (2022) Yazen Alnefeesi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Increased global integration in the brain after psilocybin therapy for depression
- (2022) Richard E. Daws et al. NATURE MEDICINE
- The promises and perils of psychedelic pharmacology for psychiatry
- (2022) Tristan D. McClure-Begley et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice
- (2022) Błażej D. Pędzich et al. NEUROPSYCHOPHARMACOLOGY
- Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
- (2022) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits
- (2022) Danica Nogo et al. PSYCHOPHARMACOLOGY
- Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
- (2022) Jacob S. Aday et al. PSYCHOPHARMACOLOGY
- Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors
- (2022) Hildegard A. Wulf et al. PSYCHOPHARMACOLOGY
- 5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
- (2022) Kazuhito Nakao et al. Translational Psychiatry
- Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
- (2022) Drummond E-Wen McCulloch et al. Frontiers in Pharmacology
- Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States
- (2022) Charles L. Raison et al. Frontiers in Psychiatry
- Glutamate Efflux across the Blood–Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System
- (2022) Benjamin Fredrick Gruenbaum et al. Metabolites
- Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
- (2022) Andrzej Pilc et al. Expert Opinion on Drug Discovery
- Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
- (2022) Adam Wojtas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual action of ketamine confines addiction liability
- (2022) Linda D. Simmler et al. NATURE
- Sustained effects of single doses of classical psychedelics in humans
- (2022) Gitte M. Knudsen NEUROPSYCHOPHARMACOLOGY
- Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents
- (2022) Caroline T. Golden et al. Scientific Reports
- Nootropic effects of LSD: Behavioral, molecular and computational evidence
- (2022) Isis M. Ornelas et al. EXPERIMENTAL NEUROLOGY
- Arketamine, a new rapid-acting antidepressant: A historical review and future directions
- (2022) Ji-chun Zhang et al. NEUROPHARMACOLOGY
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
- (2022) Guy M. Goodwin et al. NEW ENGLAND JOURNAL OF MEDICINE
- (2R,6R)-hydroxynorketamine acts through GluA1-induced synaptic plasticity to alleviate PTSD-like effects in rat models
- (2022) Yu Li et al. Neurobiology of Stress
- Ketamine rapidly enhances glutamate-evoked dendritic spinogenesis in medial prefrontal cortex through dopaminergic mechanisms
- (2021) Mingzheng Wu et al. BIOLOGICAL PSYCHIATRY
- Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
- (2021) Jason Ng et al. PSYCHOPHARMACOLOGY
- Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice
- (2021) Shigeo Miyata et al. Molecular Brain
- Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials
- (2021) Amna Majeed et al. EXPERT OPINION ON EMERGING DRUGS
- Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year
- (2021) Otto Simonsson et al. HYPERTENSION
- Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
- (2021) Klara Suneson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repeated but not single administration of ketamine prolongs increases of the firing activity of norepinephrine and dopamine neurons
- (2021) Chidiebere Michael Iro et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review
- (2021) Bruno Romeo et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Associations between lifetime classic psychedelic use and markers of physical health
- (2021) Otto Simonsson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Acute Experiences During Infusions Cause Extra-Pharmacological Antidepressant Effects in Ketamine Treatment: Evidence From Randomized, Placebo-Controlled Trials
- (2021) Maximillian Greenwald et al. BIOLOGICAL PSYCHIATRY
- Psychedelic-inspired drug discovery using an engineered biosensor
- (2021) Chunyang Dong et al. CELL
- Efficacité des psychédéliques en psychiatrie, une revue systématique
- (2021) L. Berkovitch et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling
- (2021) Yuko Fujita et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metaplastic Effects of Ketamine and MK-801 on Glutamate Receptors Expression in Rat Medial Prefrontal Cortex and Hippocampus
- (2021) Alessandro Piva et al. MOLECULAR NEUROBIOLOGY
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
- (2021) Yan Wei et al. MOLECULAR PSYCHIATRY
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
- (2021) Natalie Hesselgrave et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions
- (2021) Mingzheng Wu et al. eLife
- Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers
- (2021) Jennifer L. Kruse et al. Translational Psychiatry
- Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses—A Simultaneous EEG–FMRI Study
- (2021) Patricia Duerler et al. CEREBRAL CORTEX
- Structural basis of ketamine action on human NMDA receptors
- (2021) Youyi Zhang et al. NATURE
- Therapeutic potential of ketamine for alcohol use disorder
- (2021) Stephen D. Worrell et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice
- (2021) Fan Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Agnieszka Pałucha-Poniewiera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Serotonin toxicity of serotonergic psychedelics
- (2021) Benjamin Malcolm et al. PSYCHOPHARMACOLOGY
- (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation
- (2021) Jiancheng Zhang et al. PSYCHOPHARMACOLOGY
- Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice
- (2021) Hiba Z. Vohra et al. PSYCHOPHARMACOLOGY
- Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
- (2021) Lily R. Aleksandrova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Associations between lifetime classic psychedelic use and cardiometabolic diseases
- (2021) Otto Simonsson et al. Scientific Reports
- Blinding and expectancy confounds in psychedelic randomized controlled trials
- (2021) Suresh D. Muthukumaraswamy et al. Expert Review of Clinical Pharmacology
- Mice Lacking GABAA Receptor δ Subunit Have Altered Pharmaco-EEG Responses to Multiple Drugs
- (2021) Milo Grotell et al. Frontiers in Pharmacology
- Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
- (2021) Keri Mans et al. Frontiers in Psychiatry
- Microglia Function on Precursor Cells in the Adult Hippocampus and Their Responsiveness to Serotonin Signaling
- (2021) Andrei Turkin et al. Frontiers in Cell and Developmental Biology
- Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells
- (2021) Sanah Malomile Nkadimeng et al. Journal of Inflammation Research
- The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Anna Rafało-Ulińska et al. BEHAVIOURAL BRAIN RESEARCH
- Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis
- (2021) Joakim Kofod et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo
- (2021) Paul J. Fitzgerald INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression
- (2021) Ethan Ponton et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Psychedelic‐inspired approaches for treating neurodegenerative disorders
- (2021) Hannah N. Saeger et al. JOURNAL OF NEUROCHEMISTRY
- Molecular insights into psychedelic drug action
- (2021) Samuel T. Slocum et al. JOURNAL OF NEUROCHEMISTRY
- The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway
- (2021) Anderson Camargo et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study
- (2021) Josephine Marschall et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
- (2021) Wei Yao et al. MOLECULAR PSYCHIATRY
- (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice
- (2021) Deborah Rudin et al. NEUROPSYCHOPHARMACOLOGY
- Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults
- (2021) Conor H. Murray et al. PSYCHOPHARMACOLOGY
- Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
- (2021) Meg J. Spriggs et al. Frontiers in Psychiatry
- Mechanisms of ketamine and its metabolites as antidepressants
- (2021) Evan M. Hess et al. BIOCHEMICAL PHARMACOLOGY
- Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression
- (2021) Sara de la Salle et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Low-Dose Ketamine Improves LPS-Induced Depression-like Behavior in Rats by Activating Cholinergic Anti-inflammatory Pathways
- (2020) Jinghua Zhao et al. ACS Chemical Neuroscience
- Psychedelics and Psychedelic-Assisted Psychotherapy
- (2020) Collin M. Reiff et al. AMERICAN JOURNAL OF PSYCHIATRY
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
- (2020) Gabrielle I Agin-Liebes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment
- (2020) Christoph Kraus et al. NEUROPSYCHOPHARMACOLOGY
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
- (2020) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
- (2020) Jessica R. Gilbert et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
- (2020) Matthew E. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models
- (2020) Claire J. Foldi et al. Frontiers in Neuroscience
- Some Comments on Psychedelic Research
- (2020) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
- (2020) Saurabh S. Kokane et al. BEHAVIOURAL BRAIN RESEARCH
- N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats
- (2020) Sándor Nardai et al. EXPERIMENTAL NEUROLOGY
- Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis
- (2020) Bruno Romeo et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- (2020) N. L. Mason et al. NEUROPSYCHOPHARMACOLOGY
- Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine
- (2020) Thu Ha Pham et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression
- (2020) Mikael Tiger et al. Translational Psychiatry
- Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors
- (2020) Rachael L. Sumner et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- What ketamine can teach us about the opioid system in depression?
- (2020) Laura Perez-Caballero et al. Expert Opinion on Drug Discovery
- Can ‘Floating’ Predict Treatment Response to Ketamine? Data from Three Randomized Trials of Individuals with Treatment-Resistant Depression
- (2020) Elia E. Acevedo-Diaz et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cell-type specific modulation of NMDA receptors triggers antidepressant actions
- (2020) Santosh Pothula et al. MOLECULAR PSYCHIATRY
- Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia
- (2020) Katherine Beck et al. JAMA Network Open
- Targeting metabotropic glutamate receptors for rapid-acting antidepressant drug discovery
- (2020) Laura Musazzi Expert Opinion on Drug Discovery
- Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
- (2020) Anahit Mkrtchian et al. MOLECULAR PSYCHIATRY
- Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
- (2020) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency ( EMA ) and the UK Yellow Card Scheme pharmacovigilance database‐related reports
- (2020) Nicolo' Schifano et al. LUTS-Lower Urinary Tract Symptoms
- The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
- (2020) Veronika Andrashko et al. Frontiers in Psychiatry
- Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study
- (2020) Leo R. Silberbauer et al. Frontiers in Psychiatry
- Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
- (2020) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant actions of ketamine engage cell-specific translation via eIF4E
- (2020) Argel Aguilar-Valles et al. NATURE
- A non-hallucinogenic psychedelic analogue with therapeutic potential
- (2020) Lindsay P. Cameron et al. NATURE
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- (2020) Antonio Inserra et al. PHARMACOLOGICAL REVIEWS
- Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus
- (2020) Mohammed E.A. Elhussiny et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The role of dissociation in ketamine’s antidepressant effects
- (2020) Elizabeth D. Ballard et al. Nature Communications
- Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects
- (2019) Brendan D. Hare et al. Nature Communications
- (2R,6R)-hydroxynorketamine exerts mGlu2receptor-dependent antidepressant actions
- (2019) Panos Zanos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression
- (2019) Marlene P. Freeman et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine
- (2019) Shigeyuki Chaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lack of dopamine D1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model
- (2019) Lijia Chang et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine improved depressive-like behaviors via hippocampal glucocorticoid receptor in chronic stress induced- susceptible mice
- (2019) Wei Wang et al. BEHAVIOURAL BRAIN RESEARCH
- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- An immune gate of depression – early neuroimmune development in the formation of the underlying depressive disorder
- (2019) Małgorzata Kowalczyk et al. Pharmacological Reports
- Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
- (2019) Xavier López-Gil et al. ACS Chemical Neuroscience
- An update on NMDA antagonists in depression
- (2019) Bartłomiej Pochwat et al. Expert Review of Neurotherapeutics
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
- (2019) Yukio Ago et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms
- (2019) Eleonora Iob et al. MOLECULAR PSYCHIATRY
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- Classical psychedelics for the treatment of depression and anxiety: A systematic review
- (2019) Silvia Muttoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
- (2019) Elia E. Acevedo-Diaz et al. JOURNAL OF AFFECTIVE DISORDERS
- 5-HT2 receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model
- (2019) Thomas W. Flanagan et al. LIFE SCIENCES
- Activation of 5-HT2 Receptors Reduces Inflammation in Vascular Tissue and Cholesterol Levels in High-Fat Diet-Fed Apolipoprotein E Knockout Mice
- (2019) Thomas W. Flanagan et al. Scientific Reports
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
- (2019) Rebecca B. Price et al. MOLECULAR PSYCHIATRY
- Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents
- (2019) Sriparna Ghosal et al. NEUROBIOLOGY OF DISEASE
- Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms
- (2019) Taro Kato et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- 5-HT2Areceptor activation normalizes stress-induced dysregulation of GABAergic signaling in the ventral tegmental area
- (2019) Blake A. Kimmey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Gamma-Aminobutyric Acid B Receptor in Depression and Reward
- (2018) Laura H. Jacobson et al. BIOLOGICAL PSYCHIATRY
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
- (2018) Jennifer W. Evans et al. BIOLOGICAL PSYCHIATRY
- Treatment-resistant depression and peripheral C-reactive protein
- (2018) Samuel R. Chamberlain et al. BRITISH JOURNAL OF PSYCHIATRY
- Convergent Mechanisms Underlying Rapid Antidepressant Action
- (2018) Panos Zanos et al. CNS DRUGS
- Temporal coupling of field potentials and action potentials in the neocortex
- (2018) Brendon O. Watson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
- (2018) A.P. Allen et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
- (2018) Alan K Davis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- NMDAR-independent, cAMP-dependent antidepressant actions of ketamine
- (2018) Nathan H. Wray et al. MOLECULAR PSYCHIATRY
- Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
- (2018) Marta Peciña et al. MOLECULAR PSYCHIATRY
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes
- (2018) Kelly Doolin et al. PSYCHONEUROENDOCRINOLOGY
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Effects of Subanesthetic Ketamine Administration on Visual and Auditory Event-Related Potentials (ERP) in Humans: A Systematic Review
- (2018) André Schwertner et al. Frontiers in Behavioral Neuroscience
- Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice
- (2018) Mark J. Benvenga et al. Frontiers in Pharmacology
- S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT1B Receptor Dependent Mechanism in a Genetic Rat Model of Depression
- (2018) Kristian G. du Jardin et al. Frontiers in Pharmacology
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- DARK Classics in Chemical Neuroscience: Ibogaine
- (2018) Michael Wasko et al. ACS Chemical Neuroscience
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
- (2018) Chenghao Yang et al. BMC Psychiatry
- Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
- (2018) Yanling Zhou et al. BRAIN BEHAVIOR AND IMMUNITY
- Synaptic Potentiation and Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression: A Replication Study
- (2018) Allison C. Nugent et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
- (2018) Ruin Moaddel et al. PSYCHOPHARMACOLOGY
- Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
- (2018) Jia Jia et al. Frontiers in Cellular Neuroscience
- Gamma oscillations as a biomarker for major depression: an emerging topic
- (2018) Paul J. Fitzgerald et al. Translational Psychiatry
- Lack of Opioid System in the Antidepressant Actions of Ketamine
- (2018) Kai Zhang et al. BIOLOGICAL PSYCHIATRY
- Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
- (2018) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
- (2018) Matthew W. Johnson et al. PHARMACOLOGY & THERAPEUTICS
- 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
- (2017) Kai Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
- (2017) Marie Spies et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities
- (2017) Frederic Sampedro et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Administration of ketamine for unipolar and bipolar depression
- (2017) Christoph Kraus et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials
- (2017) Elizabeth D. Ballard et al. JOURNAL OF AFFECTIVE DISORDERS
- Serotonin and brain function: a tale of two receptors
- (2017) RL Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
- (2017) N Yao et al. MOLECULAR PSYCHIATRY
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
- (2017) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
- (2017) Alexandre K Wang et al. SCHIZOPHRENIA BULLETIN
- From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
- (2017) Bangshan Liu et al. Frontiers in Cellular Neuroscience
- Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
- (2017) Geoffrey E. Noller et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
- (2016) Rebecca A. Brachman et al. BIOLOGICAL PSYCHIATRY
- Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment
- (2016) Zhen Ren et al. BIOLOGICAL PSYCHIATRY
- Ketamine abuse potential and use disorder
- (2016) Yu Liu et al. BRAIN RESEARCH BULLETIN
- The effects of ketamine on the mismatch negativity (MMN) in humans – A meta-analysis
- (2016) Timm Rosburg et al. CLINICAL NEUROPHYSIOLOGY
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
- (2016) Marko A. Peltoniemi et al. CLINICAL PHARMACOKINETICS
- Psychedelics as Medicines: An Emerging New Paradigm
- (2016) DE Nichols et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
- (2016) Daniel Peterlik et al. Current Neuropharmacology
- A REVIEW OF KETAMINE ABUSE AND DIVERSION
- (2016) Sean Sassano-Higgins et al. DEPRESSION AND ANXIETY
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
- (2016) Bangkun Yang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
- (2016) Rafael Faria Sanches et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
- (2016) Theresa M Carbonaro et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
- (2016) Oliver H. Miller et al. NEUROPHARMACOLOGY
- Ketamine Treatment and Global Brain Connectivity in Major Depression
- (2016) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors
- (2016) Priscila B. Rosa et al. Pharmacological Reports
- The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors
- (2016) Danilo De Gregorio et al. PHARMACOLOGICAL RESEARCH
- Neural correlates of the LSD experience revealed by multimodal neuroimaging
- (2016) Robin L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models
- (2016) Evan J. Kyzar et al. Zebrafish
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
- (2015) Rita Haapakoski et al. BRAIN BEHAVIOR AND IMMUNITY
- Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion
- (2015) N. Khalili-Mahani et al. BRITISH JOURNAL OF ANAESTHESIA
- Ketamine and phencyclidine: the good, the bad and the unexpected
- (2015) D Lodge et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
- (2015) Patrick C. Dolder et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
- (2015) Anna Rickli et al. NEUROPHARMACOLOGY
- Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors
- (2015) Jonathan Fischell et al. NEUROPSYCHOPHARMACOLOGY
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
- (2015) Manabu Fuchikami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus
- (2015) Nan Wang et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression
- (2014) E. Drewniany et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes
- (2014) Bruce E. Blough et al. PSYCHOPHARMACOLOGY
- Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?
- (2014) Benjamin Rolland et al. Biomed Research International
- A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
- (2014) H Yamanaka et al. Translational Psychiatry
- Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
- (2014) N Lally et al. Translational Psychiatry
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
- (2013) Vyara Valkanova et al. JOURNAL OF AFFECTIVE DISORDERS
- Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
- (2013) E. Nosyreva et al. JOURNAL OF NEUROSCIENCE
- Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression
- (2013) Andrew H Miller NEUROPSYCHOPHARMACOLOGY
- NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
- (2013) Adam K Walker et al. NEUROPSYCHOPHARMACOLOGY
- Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
- (2013) Rafael Lugo-Huitrón et al. Oxidative Medicine and Cellular Longevity
- Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
- (2013) Felix Nau et al. PLoS One
- Monoamine neurocircuitry in depression and strategies for new treatments
- (2013) Michel Hamon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Mechanisms of Gamma Oscillations
- (2012) György Buzsáki et al. Annual Review of Neuroscience
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
- (2012) Xiaochen Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Multifaceted effects of rapamycin on functional recovery after spinal cord injury in rats through autophagy promotion, anti-inflammation, and neuroprotection
- (2012) Hsien-Chih Chen et al. JOURNAL OF SURGICAL RESEARCH
- Anhedonia Predicts Poorer Recovery Among Youth With Selective Serotonin Reuptake Inhibitor Treatment–Resistant Depression
- (2012) Dana L. McMakin et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades
- (2012) Hannah K. Delille et al. NEUROPHARMACOLOGY
- The Default Mode Network and Recurrent Depression: A Neurobiological Model of Cognitive Risk Factors
- (2012) Igor Marchetti et al. NEUROPSYCHOLOGY REVIEW
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
- (2012) André Schmidt et al. PSYCHOPHARMACOLOGY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments
- (2011) André Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
- (2011) R. Uher et al. PSYCHOLOGICAL MEDICINE
- Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
- (2011) Cinnamon Stetler et al. PSYCHOSOMATIC MEDICINE
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Wishing Away Inflammation? New Links between Serotonin and TNF Signaling
- (2010) M. Pelletier et al. MOLECULAR INTERVENTIONS
- Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus
- (2010) Y. I. Sheline et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression
- (2010) Marta Kubera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover
- (2010) Igor Branchi PSYCHONEUROENDOCRINOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
- (2009) Ciara McCabe et al. BIOLOGICAL PSYCHIATRY
- Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study
- (2009) Jonathan Price et al. BRITISH JOURNAL OF PSYCHIATRY
- Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor- -Induced Inflammation with Extraordinary Potency
- (2008) B. Yu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
- (2008) Karsten Heekeren et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More